NSIM
SEEL

North Star Investment Management’s Seelos Therapeutics, Inc. Common Stock SEEL Stock Holding History

North Star Investment Management’s Portfolio SEEL Stock Details SEEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-5
Closed -$25.1K – 1306
2023
Q2 		$25.1K Buy
+5
New +$17.3K ﹤0.01% 710
2013
Q3 		– Hold
0
– -$240K – 284
2013
Q2 		– Hold
0
– – – 249

Other funds holding SEEL

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
GJL
Gendell Jeffrey L $7.34B AUM 183.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WE
Wealth Effects Boston, Massachusetts $370M AUM 97.79% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MWM
Modera Wealth Management Westwood, New Jersey $9.37B AUM 23.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

North Star Investment Management's SEEL Position: Q3 2023 in Review

North Star Investment Management sold out of Seelos Therapeutics, Inc. Common Stock (SEEL) in Q3 2023, closing a stake of 5 shares — an estimated $25.1K sold.

North Star Investment Management first reported a position in SEEL in Q2 2023 and held it in 1 quarter. The position peaked at $25.1K in Q2 2023. 67 funds tracked by Wall St. Rank hold SEEL as of Q3 2023.

  • North Star Investment Management reported no remaining Seelos Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • North Star Investment Management sold 5 Seelos Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $25.1K.
  • North Star Investment Management first reported a position in Seelos Therapeutics, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
  • North Star Investment Management's Seelos Therapeutics, Inc. Common Stock position peaked at $25.1K in Q2 2023.
  • 67 funds tracked by Wall St. Rank held Seelos Therapeutics, Inc. Common Stock as of Q3 2023.

Based on North Star Investment Management's 13F filing for Q3 2023, filed 6 Nov 2023.